The researchers identified new combinations of mutated genes and drugs that could provide the platform for future cancer therapies.
Researchers and business leaders unveil their plan for HGP-write to synthesize full genomes.
A proposal published in Science lays out a vision to drive down the cost of fabricating genomes and accelerate research and innovation in synthetic biology.
Harvard's George Church says that a project to create synthetic human genomes at the center of last week's controversial meeting is at the 'thought experiment' stage.
Researchers have developed a programming language to design computational circuits for living cells.
Craig Venter and his colleagues develop a minimal bacterial genome of 473 genes, though the function of a third of those genes is unknown.
Following the latest financing and a recently completed Series C round, Twist has raised a total of $133 million since it was founded in 2013.
SGI will use unique DNA design, DNA synthesis, genome editing, and genome modification tools to develop engineered primary pig cells with modified genomes.
Gen9 is licensing Synthetic Genomics' Febit IP, which covers methods for low-cost oligonucleotide synthesis and retrieval of sequence-validated DNA.
The synthetic DNA firm will use the funding to accelerate into a beta commercial launch in the fall.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.